Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients

Starting soon

Conditions studied: Renal Carcinoma

In brief

This observational study is designed to expand the current database available in the literature and the existing knowledge on the outcomes and safety of radiofrequency ablation (RFA) for the treatment of primary renal cell carcinomas in stage T1a. All interventions and subsequent follow-ups are clinical decisions are independent of the study, given its observational nature.

Key facts

Study ID

NCT07465458

Run by

Humanitas Hospital, Italy

People needed

226

Starts

2026-03-01

Expected to finish

2028-06-01

Last updated by the study team

2026-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years
• Signed informed consent approved by the Ethics Committee prior to the ablation procedure.
• RCC in stage T1a (size <4 cm), single or multiple, histologically demonstrated by percutaneous biopsy before or within 30 days prior to ablation
• Absence of comorbidities that contraindicate treatment
• Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0-2 at baseline screening.

You may not qualify if…

• No specific exclusion criteria are established for this clinical registry due to its observational nature. Each center will apply its own criteria according to its routine clinical practice.

Where it is running

• IRCCS Ospedale San Raffaele — Milan, Milano, Italy
• Fondazione Poliambulanza Istituto Ospedaliero — Brescia, Italy
• Istituto Europeo di Onclologia ( IEO) — Milan, Italy
• Policlinico Universitario Campus Bio-Medico — Roma, Italy
• Hospital Clínico Universitario — Barcelona, Spain
• Hospital Universitario Reina Sofía — Córdoba, Spain
• Hospital Universitario de Leganés (Severo Ochoa) — Madrid, Spain
• Hospital Universitario Fundación Jiménez Díaz — Madrid, Spain
• Hospital Universitario Puerta de Hierro — Madrid, Spain
• Hospital Universitario Donostia — San Sebastián, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.